Magnetic resonance imaging with contrast enhanced phase angle reconstruction

• US 5,352,979 A
• Filed: 08/07/1992
• Issued: 10/04/1994
• Est. Priority Date: 08/07/1992
• Status: Expired due to Term

• Current Assignee: Thomas E. Conturo
• Original Assignee: Thomas E. Conturo
• Inventors: Conturo, Thomas E.
• Primary Examiner(s): ARANA, LOUIS M
• Application Number:
  US07/927,120
• Time in Patent Office: 788 Days
• Field of Search: 324/307, 324/309, 324/312, 128/653.4, 128/653.2, 128/654
• US Class Current: 324/307
• CPC Class Codes: G01R 33/5601 involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent
• CPC Class Codes: G01R 33/56308 Characterization of motion or flow; Dynamic imaging
• CPC Class Codes: G01R 33/56316 involving phase contrast techniques

Abstract

The magnetic resonance image of a specimen is encoded by the phase angle response of the volume elements in a slice or volume illuminated by a pulsed radio frequency source, instead of encoded by the magnitude response. The specimen can be imaged before and during intrinsic perturbations such as caused by external stimuli or execution of cognitive or motor tasks. Preferably the specimen is perfused with a paramagnetic contrast agent such as Gadolinium or Dysprosium, slowly or by bolus injection, after recording one or more baseline images. The phase angle response of the specimen can then be recorded one or more times as perturbation subsists or as the bolus traverses the area of illumination. Fast Fourier transformation converts gradient spin echo response data to phase angles for a spatial distribution of volume elements in the illuminated slice. The baseline phase angle image is subtracted from the image taken after the bolus injection, providing a high contrast image showing the concentration of the contrast agent. The change Δφ in phase angle between the images is proportional to the concentration of the contrast agent, enabling accurate measurements of localized blood volume and flow rate. The invention is particularly applicable to visualization of localized ischemia caused by cerebral vascular disease, such as stroke.

Claims

1. A method for imaging a specimen comprising one of a substance traversed by passages and a material having a changeable magnetization, comprising the steps of:

illuminating the specimen along at least one plane traversing the localized area, using a pulsed radio frequency source, and collecting at least one baseline sample representing an electromagnetic response of the specimen to the pulsed radio frequency source;

altering a magnetic property of the specimen by one of perfusing the specimen with an agent having a magnetic property different from a corresponding magnetic property of the specimen at least in a localized area to be imaged, and physically perturbing the specimen to induce a macroscopic change in the magnetic property;

illuminating the specimen along at least one plane traversing the localized area, using the pulsed radio frequency source;

collecting a plurality of data samples representing the electromagnetic response of the specimen, including the agent, to the pulsed radio frequency source;

converting the data samples into a map of phase information for an array of volume elements in said plane to thereby construct an image from variations in the electromagnetic responses of the volume elements as represented by different shifts in one of frequency, phase, real, imaginary and complex signal information between the source illuminating the specimen and the data samples collected therefrom;

correcting phase angles representing the volume elements in the array to cancel variations that are present in both the data samples and the baseline sample; and

,

identifying variations in the localized area by corresponding variations in phase information of the volume elements in said map.

2. The method according to claim 1, comprising collecting a plurality of said samples, and correcting the phase angles of the volume elements in said map by canceling variations which are present in both of two selected subsets of the samples, the subsets respectively including at least one baseline sample taken prior to said altering step, at least one data sample taken after the altering step, selected groups taken from a plurality of data samples and baseline samples, and selected averages including the data samples and baseline samples.

3. The method according to claim 1, wherein the specimen is a biological specimen having tissues traversed by vascular passages, and wherein the altering step includes infusing the specimen with a paramagnetic contrast agent which perfuses the tissues.

4. The method according to claim 2, wherein at least one of the baseline samples and the data samples are collected repetitively over a range of different gradient echo parameters, and further comprising selecting among the baseline and data samples of different gradient echo parameters in order to maximize contrast in the phase angles.

5. The method according to claim 2, wherein the phase differences are produced by multiplying complex signals by a phase factor for at least one of improving signal to noise ratio and reducing wraparound.

6. The method according to claim 5, wherein an average baseline phase is computed from an argument of an average baseline complex signal.

7. The method according to claim 4, wherein the converting step includes performing a Fourier transformation on the samples along a group of gradient echo parameters, for at least one of improving a signal-to-noise ratio of the samples, minimizing phase wraparound, and assessment of intravoxel phase distribution.

8. The method according to claim 3, wherein the altering step comprises bolus-injecting the paramagnetic contrast agent, prior to collecting the data samples.

9. The method according to claim 1, wherein the agent comprises at least one paramagnetic Lanthanide element.

10. The method according to claim 9, wherein the agent comprises at least one of Dysprosium (Dy) and Gadolinium (Gd).

11. The method according to claim 1, wherein the specimen is a biological specimen having tissues traversed by vascular passages, and wherein the agent includes intrinsic blood having a variation from nominal intrinsic blood in one of an oxygenation level and an oxidation state thereof, said variation being produced by one of a physiologic characteristic of the specimen and an externally induced change.

12. The method according to claim 1, wherein the specimen comprises biological tissue and wherein said perturbation includes at least one of irradiation, application of light application of heat, application of sound, sensory stimulus motor stimulus application of balloon angioplasty, application of pharmacologic agents and execution of a cognitive task.

13. The method according to claim 10, wherein the agent is chosen from the group consisting of diamagnetic, ferromagnetic and superparamagnetic species.

14. The method according to claim 3, wherein the localized area includes cerebral tissue and the passages are vascular structures.

15. The method according to claim 1, wherein the localized area includes tissue of at least one of a cerebrum, extracerebral brain tissue, myocardium, spinal cord, kidney, liver, spleen, bowel, pancreas, skeletal muscle, lung, bone marrow, and connective tissue.

16. The method according to claim 1, and further comprising displaying said phase angle map using variations in at least one of luminance, saturation and hue to encode variations in phase angle.

17. The method according to claim 16, wherein the sample comprises cerebral tissue and the passages are vascular structures, and wherein said identifying step includes computer analyzing the map for a localized area of ischemia characterized by localized variations in the phase angles.

18. The method according to claim 16, wherein the sample comprises cerebral tissue and the flow passages are vascular structures including large arteries, veins, arterioles and venules, and small capillaries, and wherein the variations represent at least one of a tumor, infection, hematoma, embolism and infarction.

19. The method according to claim 16, wherein the localized area includes tissue of at least one of a cerebrum, extracerebral brain tissue, myocardium, spinal cord, kidney, liver, spleen, bowel, pancreas skeletal muscle, lung, bone marrow, and connective tissue, said identifying step including computer analyzing the map for localized variations in the phase angles characterizing an area of at least one of ischemia, tumor, hematoma, infection, embolism and infarction.

20. The method according to claim 19, further comprising assessing from the map at least one of absolute blood volume, relative blood volume, absolute blood flow, relative blood flow, and mean transit time, in a region of interest in the localized area.

21. An apparatus for magnetic resonance imaging, comprising:

a source of a pulsed radio frequency signal for illumination of a specimen along at least one plane traversing the specimen;

sampling means operable to acquire a plurality of data samples representing at least one of an electromagnetic gradient echo response and a spin echo response of the specimen to the pulsed radio frequency signal;

data processing means operable to store at least two sets of said data samples corresponding to successive responses of the specimen to the pulsed radio frequency signal, the data processing means including a Fourier transform means operable to convert the data samples to complex intensities, and the data processing means converting the complex intensities to a map of phase information representing a phase response of individual volume elements in the plane to the pulsed radio frequency signal through a macroscopic volume of the specimen, and means for correcting the phase response of the individual volume elements in a second of the two sets from a first of the two sets;

means for altering a magnetic property of the specimen in the macroscopic volume, between acquisition of the two sets; and

,

a display coupled to the data processing means for graphic representation of the phase response of the individual volume elements.

22. The apparatus according to claim 21, further comprising triggering means coupled to the source and the sampling means, the triggering means being operable for at least one of monitoring physiologic signals from the specimen, initiating external stimuli of the specimen, and triggering the source and the sampling means respectively to illuminate the specimen and to collect the data samples.

23. The apparatus according to claim 21, wherein the data processor is operable to process said data samples for quantification of at least one of rCBV, rCBF, and MTT.

24. The apparatus according to claim 21, further comprising means for physically perturbing the specimen for producing a change in said response at least in a localized area of the specimen.

25. The apparatus according to claim 21, further comprising means coupled to the specimen for blood sampling in connection with data acquisition.

26. The apparatus according to claim 21, wherein the agent comprises one of a paramagnetic contrast agent and an agent for altering a physiologic characteristic of blood.

27. The apparatus according to claim 26, wherein the means for altering comprises a bolus injection means operable to infuse a quantity of the paramagnetic contrast agent into a vascular passage of the specimen.

28. The apparatus according to claim 21, wherein the sampling means and the data processing means are operable in conjunction to acquire a plurality of successive responses of the specimen at different gradient echo parameters, and further comprising means for selecting alternative presentations for said graphic representation, whereby contrast can be maximized.

29. The apparatus according to claim 28, wherein the data processing means is operable to compute a baseline phase map from an argument of an average baseline complex signal calculated from a plurality of baseline data acquisitions.

30. The apparatus according to claim 21, wherein the sampling means is operable to encode a magnetic resonance spin echo pulse sequence response of the specimen.

31. The apparatus according to claim 21, wherein the sampling means is operable to encode a steady state free precession pulse sequence response.

32. The apparatus according to claim 21, wherein the sampling means is operable to encode an at least a partly echo planar spatial encoding pulse sequence.

33. The apparatus according to claim 21, further comprising triggering means coupled to the specimen and operable to initiate collection of an image at a predetermined time, whereby motion and artifacts in the map are reduced.

34. The apparatus according to claim 33, wherein the triggering means comprises a cardiorespiratory gating trigger operable for at least one of initiating collection of the image at a predetermined point in a cardiorespiratory cycle, providing cardiorespiratory data for retrospective processing of the data samples, initiating application of an external stimulus to the specimen, and enabling an external triggering means to initiate data acquisition.

35. The apparatus according to claim 22, wherein the triggering means is operable to effect at least one of EKG tracking, respiratory monitoring, EEG tracking and triggering of additional magnetic resonance imaging signals for at least one of reducing motion artifacts and collection of an image at least at one predetermined point in cardiac and respiratory cycles of the specimen.